NYS: NU
Before the Bell
--Quotes are delayed by 20 min
Nov 30, 2023, 6:29 a.m.
$
8.29
Change
+0.07 +0.85%
Volume
Volume 117
Quotes are delayed by 20 min
Previous close
$ 8.22
$ 8.22
Change
+0.12 +1.48%
Day low
Day high
$8.16
$8.36
52 week low
52 week high
$3.39
$8.87
Mr. David V?lez Osorno Chairman & Chief Executive Officer |
Mr. Youssef Lahrech President & Chief Operating Officer |
Mr. Guilherme Marques do Lago Chief Financial Officer |
Mr. Vitor Guarino Olivier Chief Technology Officer |
Ms. Cristina Helena Zingaretti Junqueira Chief Growth Officer & CEO-Brazil |
Mr. Alex Ceballos Director-Corporate Development |
Mr. Jagpreet Singh Duggal Chief Product Officer |
Mr. Henrique Camossa Saldanha Fragelli Chief Risk Officer |
Mr. Thuan Q. Pham Director |
Mr. David A. Marcus Director |
Ms. Suzana Kubric Vice President-People & Culture |
Mr. Marco Antonio Martins de Araujo Filho Director-Legal & Public Policy |
Dr. Anita Mary Sands Independent Director |
Dr. Daniel Krepel Goldberg Independent Director |
Mr. Luis Alberto Moreno Independent Director |
Ms. Jacqueline Dawn Reses Independent Director |
Mr. Rog?rio Paulo Calder?n Peres Independent Director |
Mr. Douglas Mauro Leone Independent Director |
Musk Warns of Troubles at X. What Its Demise Could Mean for Tesla.
Ford sees 2023 adj. FCF of $5.0B-$5.5B, above the FactSet consensus of $4.26B
Salesforce stock price target raised to $280 from $255 at Wedbush
STMicroelectronics upgraded to overweight from neutral at J.P. Morgan
VAT Group upgraded to overweight from neutral at J.P. Morgan
Ericsson downgraded to neutral from overweight at J.P. Morgan
CNX Resources upgraded to buy from neutral at Gerdes Energy Research
Salesforce stock price target raised to $230 from $200 at D.A. Davidson
Trivago stock price target raised to $2.50 from $1.00 at Susquehanna
Kulr Technology started at speculative buy with $1 stock price target at Benchmark
Nuvei started at buy with $25 stock price target at Seaport Research
I don’t want to leave my financially irresponsible daughter my house. Is that unreasonable?
KKR and Hologic team up to create medical tech platform focused on lung cancer diagnostics
Virtual Stock Exchange